- Home
- ASTS vs NBIX Comparison
ASTS vs NBIX Comparison
Compare ASTS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTS
- NBIX
- Stock Information
- Founded
- ASTS 2019
- NBIX 1992
- Country
- ASTS United States
- NBIX United States
- Employees
- ASTS N/A
- NBIX N/A
- Industry
- ASTS Telecommunications Equipment
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASTS Consumer Discretionary
- NBIX Health Care
- Exchange
- ASTS Nasdaq
- NBIX Nasdaq
- Market Cap
- ASTS 13.6B
- NBIX 14.4B
- IPO Year
- ASTS N/A
- NBIX 1996
- Fundamental
- Price
- ASTS $81.33
- NBIX $139.01
- Analyst Decision
- ASTS Hold
- NBIX Strong Buy
- Analyst Count
- ASTS 8
- NBIX 17
- Target Price
- ASTS $45.82
- NBIX $163.71
- AVG Volume (30 Days)
- ASTS 15.3M
- NBIX 865.6K
- Earning Date
- ASTS 11-13-2025
- NBIX 10-28-2025
- Dividend Yield
- ASTS N/A
- NBIX N/A
- EPS Growth
- ASTS N/A
- NBIX 2.97
- EPS
- ASTS N/A
- NBIX 3.39
- Revenue
- ASTS $4,892,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- ASTS $1,257.31
- NBIX $20.79
- Revenue Next Year
- ASTS $343.93
- NBIX $14.73
- P/E Ratio
- ASTS N/A
- NBIX $41.02
- Revenue Growth
- ASTS 249.43
- NBIX 18.42
- 52 Week Low
- ASTS $17.50
- NBIX $84.23
- 52 Week High
- ASTS $91.41
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- ASTS 84.76
- NBIX 47.46
- Support Level
- ASTS $67.28
- NBIX $135.96
- Resistance Level
- ASTS $52.38
- NBIX $141.14
- Average True Range (ATR)
- ASTS 5.22
- NBIX 3.12
- MACD
- ASTS 3.81
- NBIX -1.11
- Stochastic Oscillator
- ASTS 94.23
- NBIX 13.09
About ASTS AST SpaceMobile Inc.
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.